← Research library

Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus.

Lab research · 2006

What was studied
Human T-cell cultures exposed to tumor-conditioned medium or measles virus
Main finding
MP-2 (LVVYPW) restored IL-2 production and receptor expression in experimentally suppressed human T cells. Human-derived cells do not make this a human treatment trial.

Study data at a glance

Participants or experimental model
Human T-cell cultures exposed to tumor-conditioned medium or measles virus
Reported results
MP-2 (LVVYPW) restored IL-2 production and receptor expression in experimentally suppressed human T cells. Human-derived cells do not make this a human treatment trial.
Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

In vitroEnglish abstract

Mikhailova AA, Belevskaya RG, Kalyuzhnaya M, Fonina LA, Liashenko VA, Petrov RV. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus. Journal of immunotherapy (Hagerstown, Md. : 1997)

Study source ↗ · DOI 10.1097/01.cji.0000188366.84341.c3 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards